Search

Robert Edward Fuller

Examiner (ID: 11117, Phone: (571)272-6300 , Office: P/3676 )

Most Active Art Unit
3676
Art Unit(s)
3672, 3676
Total Applications
1083
Issued Applications
812
Pending Applications
95
Abandoned Applications
204

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17473970 [patent_doc_number] => 20220081474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => Nucleic Acids for Treatment of Allergies [patent_app_type] => utility [patent_app_number] => 17/028762 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028762 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028762
Nucleic Acids for Treatment of Allergies Sep 21, 2020 Pending
Array ( [id] => 17830078 [patent_doc_number] => 20220267382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 17/627212 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627212 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627212
CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME Sep 17, 2020 Pending
Array ( [id] => 17830078 [patent_doc_number] => 20220267382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 17/627212 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627212 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627212
CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME Sep 17, 2020 Pending
Array ( [id] => 16710380 [patent_doc_number] => 20210077527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS [patent_app_type] => utility [patent_app_number] => 17/018681 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/018681
UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS Sep 10, 2020 Pending
Array ( [id] => 16673111 [patent_doc_number] => 20210061874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => CLAUDIN-6 PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/017444 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017444 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017444
CLAUDIN-6 PEPTIDES Sep 9, 2020 Abandoned
Array ( [id] => 16657401 [patent_doc_number] => 20210054037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => PEPTIDES OF PAGE5 [patent_app_type] => utility [patent_app_number] => 17/017457 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017457 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017457
PEPTIDES OF PAGE5 Sep 9, 2020 Abandoned
Array ( [id] => 16628731 [patent_doc_number] => 20210047384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => SYNTAC POLYPEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/015282 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015282 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015282
SYNTAC POLYPEPTIDES AND USES THEREOF Sep 8, 2020 Pending
Array ( [id] => 16657400 [patent_doc_number] => 20210054036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/013228 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013228 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/013228
PEPTIDES Sep 3, 2020 Abandoned
Array ( [id] => 16657409 [patent_doc_number] => 20210054045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/010653 [patent_app_country] => US [patent_app_date] => 2020-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/010653
PEPTIDES Sep 1, 2020 Abandoned
Array ( [id] => 16523797 [patent_doc_number] => 20200397877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => ENHANCING T CELL ACTIVATION USING ALTERED MHC-PEPTIDE LIGANDS [patent_app_type] => utility [patent_app_number] => 17/009613 [patent_app_country] => US [patent_app_date] => 2020-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009613 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/009613
Enhancing T cell activation using altered MHC-peptide ligands Aug 31, 2020 Issued
Array ( [id] => 17895437 [patent_doc_number] => 20220305099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS [patent_app_type] => utility [patent_app_number] => 17/638576 [patent_app_country] => US [patent_app_date] => 2020-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -83 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638576 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638576
METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS Aug 25, 2020 Abandoned
Array ( [id] => 17895437 [patent_doc_number] => 20220305099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS [patent_app_type] => utility [patent_app_number] => 17/638576 [patent_app_country] => US [patent_app_date] => 2020-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -83 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638576 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638576
METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS Aug 25, 2020 Abandoned
Array ( [id] => 17007093 [patent_doc_number] => 20210238254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => SYNTAC POLYPEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/001847 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001847 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/001847
SYNTAC POLYPEPTIDES AND USES THEREOF Aug 24, 2020 Abandoned
Array ( [id] => 16628976 [patent_doc_number] => 20210047629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => PEPTIDES DERIVED FROM KALLIKREIN 4 [patent_app_type] => utility [patent_app_number] => 16/998945 [patent_app_country] => US [patent_app_date] => 2020-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998945 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/998945
PEPTIDES DERIVED FROM KALLIKREIN 4 Aug 19, 2020 Abandoned
Array ( [id] => 16673094 [patent_doc_number] => 20210061857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => PEPTIDES FROM PIWIL1 [patent_app_type] => utility [patent_app_number] => 16/994399 [patent_app_country] => US [patent_app_date] => 2020-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994399 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/994399
PEPTIDES FROM PIWIL1 Aug 13, 2020 Abandoned
Array ( [id] => 16482492 [patent_doc_number] => 20200376092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => FRAGMENTS OF P97 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/992821 [patent_app_country] => US [patent_app_date] => 2020-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/992821
FRAGMENTS OF P97 AND USES THEREOF Aug 12, 2020 Abandoned
Array ( [id] => 20373526 [patent_doc_number] => 12480958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Method for the characterization of peptide:MHC binding polypeptides [patent_app_type] => utility [patent_app_number] => 16/990701 [patent_app_country] => US [patent_app_date] => 2020-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8508 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990701 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/990701
Method for the characterization of peptide:MHC binding polypeptides Aug 10, 2020 Issued
Array ( [id] => 19586405 [patent_doc_number] => 20240383962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => GENETICALLY ENGINEERED CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/634963 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634963 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634963
GENETICALLY ENGINEERED CELLS AND USES THEREOF Aug 9, 2020 Pending
Array ( [id] => 19586405 [patent_doc_number] => 20240383962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => GENETICALLY ENGINEERED CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/634963 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634963 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634963
GENETICALLY ENGINEERED CELLS AND USES THEREOF Aug 9, 2020 Pending
Array ( [id] => 16613648 [patent_doc_number] => 20210032301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/988425 [patent_app_country] => US [patent_app_date] => 2020-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988425 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/988425
PEPTIDES Aug 6, 2020 Abandoned
Menu